- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05903677
The Relationship Between Preoperative Levels of Ionized Magnesium and Risk of Acute Kidney Injury After Cardiac Surgery
June 11, 2023 updated by: Mostafa Ahmed Kaleed Abdelhalim, Assiut University
Detection the relationship between preoperative ionized magnesium levels and the risk of acute kidney injury after cardiac surgery.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Acute kidney injury (AKI) is a major medical problem that is of particular concern after cardiac surgery.
The reported prevalence of cardiac surgery-associated acute kidney injury (CSA-AKI) is up to 30% and is independently associated with an increase of morbidity and mortality .So this study is for measuring preoperative ionized magnesium levels of patients who will undergo cardiac surgeries then measuring postoperative serum creatinine, BUN and urine output to detect if they developed AKI or not and if there is a relationship between the post cardiac surgery AKI and preoperative ionized magnesium levels.
Study Type
Observational
Enrollment (Estimated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mostafa Ahmed
- Phone Number: 01113038074
- Email: mostafakaleed21@gmail.com
Study Contact Backup
- Name: Samir Kamal
- Phone Number: 01062949199
- Email: samirkotb45@yahoo.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
people more than or equal 18 years who undergo open heart surgery between July 2023 to July 2024 and not known to have kidney disease .
Description
Inclusion Criteria:
- patients more than or equal 18 yrs.
- patients undergoing cardiac surgery between July 2023 and July 2024
Exclusion Criteria:
- patients with known Kidney disease.
- patients less than 18 yrs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Adults undergoing cardiac surgery without preoperative renal affection
Detect the preoperative magnesium levels in adults undergoing cardiac surgery without preoperative renal affection and follow up if they developed postoperative acute kidney injury or not.
|
Detection of the relationship between cardiac surgery associated AKI and preoperative magnesium levels.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post cardiac surgery AKI according to KDIGO criteria with low preoperative magnesium level
Time Frame: Baseline
|
Measuring preoperative magnesium level and postoperative kidney functions in form of serum creatinine in umol/L , BUN in mmol/L and urine output ml/h to detect the relationship between preoperative low magnesium level and risk of acute kidney injury after cardiac surgery.
|
Baseline
|
|
Post cardiac surgery AKI according to KDIGO criteria with normal or high preoperative magnesium level
Time Frame: basline
|
Measuring preoperative magnesium level and postoperative serum creatinine, BUN and urine output to detect the relationship between preoperative magnesium level and risk of acute kidney injury after cardiac surgery.
|
basline
|
|
Post cardiac surgery normal kidney functions with low preoperative magnesium level
Time Frame: basline
|
Measuring preoperative magnesium level and postoperative serum creatinine, BUN and urine output to detect the relationship between preoperative magnesium level and risk of acute kidney injury after cardiac surgery.
|
basline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 1, 2023
Primary Completion (Estimated)
June 1, 2024
Study Completion (Estimated)
July 1, 2024
Study Registration Dates
First Submitted
June 2, 2023
First Submitted That Met QC Criteria
June 11, 2023
First Posted (Actual)
June 15, 2023
Study Record Updates
Last Update Posted (Actual)
June 15, 2023
Last Update Submitted That Met QC Criteria
June 11, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Preoperative magnesium and AKI
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Magnesium Disorder
-
Istanbul UniversityCompletedTransplant Dysfunction | Magnesium DisorderTurkey
-
Assiut UniversityNot yet recruitingMagnesium | Intraoperative Analgesia
-
Loma Linda UniversityRecruitingMagnesium Sulfate | Intraoperative Neurophysiological MonitoringUnited States
-
Alexandria UniversityCompletedMagnesium Sulfate | Sleeve Gastrectomy | BupivacaineEgypt
-
University of LjubljanaMasaryk UniversityCompletedMagnesium | Skeletal Muscle Contraction PropertiesCzechia, Slovenia
-
Assiut UniversityNot yet recruitingMagnesium Sulfate | Fentanyl | Neostigmine
-
Stanford UniversityCompletedMagnesium Sulfate Pharmacokinetics and PharmacodynamicsUnited States
-
Hospital Federal de BonsucessoUnknownNeuromuscular Blockade | Magnesium Sulfate | Rocuronium | Deep Neuromuscular BlockadeBrazil
-
Menoufia UniversityCompletedIntraperitoneal Magnesium Sulphate in Laparoscope in PediatricsEgypt
-
BDH-Klinik Hessisch OldendorfRecruiting
Clinical Trials on magnesium levels
-
Sohag UniversityRecruitingHepatocellular CarcinomaEgypt
-
First Affiliated Hospital Xi'an Jiaotong UniversityXi'an TCM Hospital of EncephalopathyRecruitingAutism Spectrum DisorderChina
-
Ankara Etlik City HospitalCompletedPain, Postoperative | Nausea, Postoperative | Vomiting, PostoperativeTurkey
-
Büşra SarıkayaCompleted
-
Osijek University HospitalCompletedSepsis | Gram-negative Bacteremia | Gram-Positive BacteremiaCroatia
-
Scarborough General HospitalLakeridge Health Corporation; Scarborough Health NetworkRecruiting
-
Tongji HospitalRecruitingIschemic Stroke | Ischemic Cerebrovascular DiseaseChina
-
Appalachian State UniversityU.S. National Science FoundationRecruiting
-
Ankara City Hospital BilkentCompletedGeneral Anesthesia | Elective Laparoscopic CholecystectomyTurkey (Türkiye)
-
Istanbul Medipol University HospitalCompleted